Details

Autor(en) / Beteiligte

• Jares, Edgardo José, MD
• Sánchez-Borges, Mario, MD
• Cardona-Villa, Ricardo, MD
• Ensina, Luis Felipe, MD
• Arias-Cruz, Alfredo, MD
• Gómez, Maximiliano, MD
• Barayazarra, Susana, MD
• Bernstein, Jonathan A., MD
• Serrano, Carlos D., MD
• Cuello, Mabel Noemi, MD
• Morfin-Maciel, Blanca María, MD
• De Falco, Alicia, MD
• Cherrez-Ojeda, Iván, MD, MSc

Titel

Multinational experience with hypersensitivity drug reactions in Latin America

Ist Teil von

• Annals of allergy, asthma, & immunology, 2014-09, Vol.113 (3), p.282-289

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2014

Quelle

ScienceDirect

Beschreibungen/Notizen

• Abstract Background Epidemiologic drug allergy data from Latin America are scarce, and there are no studies on specific procedures focusing on this topic in Latin America. Objective To assess the clinical characteristics and management of hypersensitivity drug reactions in different Latin American countries. Methods An European Network of Drug Allergy questionnaire survey was implemented in 22 allergy units in 11 Latin American countries to report on consecutive patients who presented with a suspected hypersensitivity drug reaction. Each unit used its own protocols to investigate patients. Results Included were 868 hypersensitivity drug reactions in 862 patients (71% of adults and elderly patients were women and 51% of children were girls, P  = .0001). Children presented with less severe reactions than adults and elderly patients ( P < .0001). Urticaria and angioedema accounted for the most frequent clinical presentations (71%), whereas anaphylaxis was present in 27.3% of cases. There were no deaths reported. Nonsteroidal anti-inflammatory drugs (52.3%), β-lactam antibiotics (13.8%), and other antibiotics (10.1%) were the drugs used most frequently. Skin prick tests (16.7%) and provocation tests (34.2%) were the study procedures most commonly used. A large proportion of patients were treated in the emergency department (62%) with antihistamines (68%) and/or corticosteroids (53%). Only 22.8% of patients presenting with anaphylaxis received epinephrine. Conclusion Nonsteroidal anti-inflammatory drugs and antibiotics were the drugs used in at least 75% of patients. More than half the reactions were treated in the emergency department, whereas epinephrine was administered in fewer than 25% of patients with anaphylaxis. Dissemination of guidelines for anaphylaxis among primary and emergency department physicians should be encouraged.